Drug
Letrozole (Aromatase Inhibitors)
Letrozole (Aromatase Inhibitors) is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
1(25%)
Phase Distribution
Ph not_applicable
2
50%
Ph phase_3
1
25%
Ph phase_1
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(3)
Other(1)
Detailed Status
Not yet recruiting2
Active, not recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 11 (25.0%)
Phase 31 (25.0%)
N/A2 (50.0%)
Trials by Status
active_not_recruiting125%
unknown125%
not_yet_recruiting250%
Recent Activity
1 active trials
Showing 4 of 4
active_not_recruitingphase_1
NT-NOA - Novel Treatment of Some Men With Non-Obstructive Azoospermia
NCT06706414
not_yet_recruitingnot_applicable
FET-LET-2x2: Clinical Pregnancy Rates After Frozen Embryo Transfer in Natural and Modified Natural Cycles
NCT07425990
not_yet_recruitingnot_applicable
Endometrial Response in Polycystic Ovarian Syndrome Treated With Letrozole Alone or With Added Estradiol Valerate
NCT07379502
unknownphase_3
Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer
NCT02769104
Clinical Trials (4)
Showing 4 of 4 trials
NCT06706414Phase 1
NT-NOA - Novel Treatment of Some Men With Non-Obstructive Azoospermia
NCT07425990Not Applicable
FET-LET-2x2: Clinical Pregnancy Rates After Frozen Embryo Transfer in Natural and Modified Natural Cycles
NCT07379502Not Applicable
Endometrial Response in Polycystic Ovarian Syndrome Treated With Letrozole Alone or With Added Estradiol Valerate
NCT02769104Phase 3
Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4